Edwards Lifesciences (EW) Tops Q4 EPS by 11c, FY15 EPS Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Edwards Lifesciences (EW) Estimates Raised at Jefferies Following 'Stellar' Q4
February 4, 2015 8:43 AM ESTJefferies analyst Raj Denhoy reiterated a Buy rating and $155 price target on Edwards Lifesciences (NYSE: EW) while raising estimates following strong q4 results.
Denhoy commented, "EW posted a stellar 4Q, highlighted by (1) robust TAVR performance across geographies, particularly EU, despite increasing competitionand the... More
